USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Technological Advances in Regenerative Medicine
Disruptive Technology and a Competitive Landscape Drive Growth in Stem Cell Therapy Research
20-Aug-2024
Global
Technology Research
DAFE-01-00-00-00
HC_2024_962
$4,950.00
Special Price $4,207.50 save 15 %
Regenerative medicine has evolved significantly and today includes several commercialized stem cell therapies. Researchers have made notable technological developments in stem cell therapies to overcome challenges related to large-scale manufacturing and cell quality. Stem cell research is more focused on induced pluripotent stem cells than on mesenchymal and hematopoietic stem cells, a transition caused by the fast-paced developments in iPSC research. Developments in technology platform help improve overall stem cell therapy and selection and reduce overall costs. Emerging companies are establishing newer cell isolation, characterization, and screening processes to ensure constant cell viability and maintenance.
Industry players increasingly adopt artificial intelligence and machine learning technologies for stem cell imaging, real-time tracking, and entering new disease areas. Stem cell therapies have huge potential in treating oncology, neurological conditions, and cardiac conditions, apart from rare diseases. Private investments and collaborations continue to drive stem cell R&D and push the clinical trial pipelines across various diseases.
This report covers incremental technological improvements and the new platforms that stakeholders have designed for stem cell therapy developments in induced pluripotent stem cells, mesenchymal stem cells, hematopoietic stem cells, and human embryonic stem cells.
Key Questions This Study Addresses:
What is the current landscape of stem cell therapy, and what are the overall trends?
What are the technology developments improving stem cell therapy R&D?
Which companies are adopting new technology platforms to scale stem cell therapy R&D?
What is the investment and partnership ecosystem in stem cell therapy development?
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Cell and Gene Therapy Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Scope of Analysis
Segmentation
Growth Drivers
Growth Restraints
Types of Common Stem Cells in Regenerative Medicine
Overall Trends in Stem Cell Therapy Development
Snapshot of the Regenerative Medicine Landscape
Ongoing Challenges in the Development of Stem Cell Therapy
Highly Adopted Stem Cells in Clinical Use to Develop Regenerative Medicine
Developments in iPSC Therapies
Developments in MSCs
Developments in HSCs
Developments in hESC Therapies
Overall Technology Adoption by Stem Cell Therapy Developers
Cell Manufacturing Platforms Enabling Stem Cell Development
Cell Manufacturing Platforms Enabling Stem Cell Development (continued)
Stem Cell Selection and Characterization Platform
AI-integrated Platforms for Stem Cell Therapy Developments
AI Platforms for Stem Cell Therapy Development
AI Platforms for Stem Cell Therapy Development (continued)
Impact of Stem Cell Therapies in Various Diseases Areas
Public Investment Trends Driving Stem Cell Therapy Research
Recent Private Investments Driving Stem Cell Therapy Research
Recent Private Investments Driving Stem Cell Therapy Research (continued)
Recent Private Investments Driving Stem Cell Therapy Research (continued)
Growing M&As in Stem Cell Therapy
Growing Partnerships
Growth Opportunity 1: Integration of AI and Automation to Improve Stem Cell Scalability
Growth Opportunity 1: Integration of AI and Automation to Improve Stem Cell Scalability (continued)
Growth Opportunity 2: Cell Engineering and Reprogramming Methods to Improve Stem Cell Quality
Growth Opportunity 2: Cell Engineering and Reprogramming Methods to Improve Stem Cell Quality (continued)
Growth Opportunity 3: Focus on Cancer First and then on Rare Diseases
Growth Opportunity 3: Focus on Cancer First and then on Rare Diseases (continued)
Technology Readiness Level (TRL): Explanations
Benefits and Impacts of Growth Opportunities
Next Steps
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Pharmaceuticals and Biotech research
21 Jan 2025 | Global | Technology Research
Technologies Enabling Resilient Pharmaceutical Supply Chains
This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model. The study answers the following questions: What are some new challenges big pharma's supp...
16 Jan 2025 | Global | Technology Research
Advanced Therapeutics for the Infectious Disease Management Market, Global, 2024-2029
Antimicrobial resistance (AMR), the emergence of new pathogens, and breakthroughs in biotechnology have significantly transformed the global landscape of infectious diseases. This Frost & Sullivan report focuses on advanced therapeutics for the infectious disease management industry. It offers an an...
28 Oct 2024 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive...
10 Sep 2024 | Global | Market Research
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029
With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market str...
10 Sep 2024 | Global | Technology Research
Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing
This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeu...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Technology Research |
|---|---|
| Author | Neeraja Vettekudath |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Regenerative Medicine Advances |
| Keyword 2 | Regenerative Therapies |
| Keyword 3 | Future of Healthcare Solutions |
| Podcast | No |
| WIP Number | DAFE-01-00-00-00 |